{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:37:24Z","timestamp":1787027844317,"version":"build-2736575974"},"reference-count":82,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["AG067473"],"award-info":[{"award-number":["AG067473"]}]},{"name":"NIH","award":["NS114221"],"award-info":[{"award-number":["NS114221"]}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"crossref","award":["RX001473"],"award-info":[{"award-number":["RX001473"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"crossref","award":["RX003865"],"award-info":[{"award-number":["RX003865"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) and stroke have been identified as risk factors for each other. More than half of AD patients suffer stroke attacks and worse ischemic injuries. There has been a lack of research focus and clinical treatment for the comorbidity of these neurological disorders. AD and ischemic stroke share characteristic pathophysiology, including hyperactivities of excitatory neurons and NMDA receptors (NMDARs), excitotoxicity, and synapse\/neurovascular destruction. Our recent investigations identified the deficiency of the NMDAR regulatory GluN3A (NR3A) subunit as a novel pathogenesis of sporadic AD. The present investigation tested a preemptive treatment to prevent AD development in two AD models and, in the meantime, to prime the susceptible brain against upcoming ischemic attacks. In the preclinical stage of 3-month-old GluN3A KO mice, an NMDAR-mediated sporadic AD model, and 5xFAD mice, an amyloid-based familial AD model, treatments with memantine (MEM), an NMDAR antagonist (10 mg\/kg\/day in drinking water) and a drug-free control were started when cognition of these mice was generally normal. Three months later, the mice were subjected to focal cerebral ischemic surgery, followed by continued 1.5\u20132.0 months of MEM or vehicle control. Morphological, pathological, and functional assessments were performed and compared at different time points. In both AD models, the early MEM treatment confined AD progression before and after stroke, reduced ischemia-induced brain injury, suppressed neuroinflammation, and improved locomotion, sensorimotor, psychological, and cognitive functions. This is the first report endorsing a shared mechanism of NMDAR hyperactivity in AD and stroke in AD models with distinctive risk factors. The dual therapeutic effects of the preemptive MEM treatment provide a disease-modifying possibility for individuals who are susceptible to sporadic or familial AD as well as ischemic stroke.<\/jats:p>","DOI":"10.3390\/cells14231871","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:56:41Z","timestamp":1764172601000},"page":"1871","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combined Preventive and Preconditioning Treatments for the Comorbidity of Alzheimer\u2019s Disease and Ischemic Stroke in a GluN3A Knockout Mouse and a 5xFAD Mouse"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1335-1398","authenticated-orcid":false,"given":"Shan Ping","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Emory University School of Medicine, 101 Woodruff Circle, Suite 617, Atlanta, GA 30322, USA"},{"name":"Center for Visual & Neurocognitive Rehabilitation, Atlanta VA Medical Center, Decatur, GA 30033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Emory University School of Medicine, 101 Woodruff Circle, Suite 617, Atlanta, GA 30322, USA"},{"name":"Center for Visual & Neurocognitive Rehabilitation, Atlanta VA Medical Center, Decatur, GA 30033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Q.","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Emory University School of Medicine, 101 Woodruff Circle, Suite 617, Atlanta, GA 30322, USA"},{"name":"Center for Visual & Neurocognitive Rehabilitation, Atlanta VA Medical Center, Decatur, GA 30033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth","family":"Sastry","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Emory University School of Medicine, 101 Woodruff Circle, Suite 617, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyue","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Emory University School of Medicine, 101 Woodruff Circle, Suite 617, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Emory University School of Medicine, 101 Woodruff Circle, Suite 617, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Emory University School of Medicine, 101 Woodruff Circle, Suite 617, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3233\/JAD-160527","article-title":"Stroke, Vascular Dementia, and Alzheimer\u2019s Disease: Molecular Links","volume":"54","author":"Vijayan","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","article-title":"Stroke injury, cognitive impairment and vascular dementia","volume":"1862","author":"Kalaria","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"16385","DOI":"10.1038\/s41598-021-95821-x","article-title":"Incident stroke in patients with Alzheimer\u2019s disease: Systematic review and meta-analysis","volume":"11","author":"Pinho","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-023-00636-1","article-title":"Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: Implications for preventive treatments of ischemic stroke and late-onset Alzheimer\u2019s disease","volume":"18","author":"Yu","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3233\/JAD-201459","article-title":"Mortality After Ischemic Stroke in Patients with Alzheimer\u2019s Disease Dementia and Other Dementia Disorders","volume":"81","author":"Zupanic","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8192","DOI":"10.1002\/alz.14223","article-title":"Ischemic staroke associated with amyloid-related imaging abnormalities in a patient treated with lecanemab","volume":"20","author":"Gibson","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1993.tb18285.x","article-title":"Altered calcium signaling and neuronal injury: Stroke and Alzheimer\u2019s disease as examples","volume":"679","author":"Mattson","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1566524043479248","article-title":"The rise and fall of NMDA antagonists for ischemic stroke","volume":"4","author":"Hoyte","year":"2004","journal-title":"Curr. Mol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JAD-215699","article-title":"Alzheimer\u2019s Disease: Key Insights from Two Decades of Clinical Trial Failures","volume":"87","author":"Kim","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Choi, D.W. (2020). Excitotoxicity: Still Hammering the Ischemic Brain in 2020. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.579953"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ana.410190202","article-title":"Glutamate and the pathophysiology of hypoxic-ischemic brain damage","volume":"19","author":"Rothman","year":"1986","journal-title":"Ann. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","article-title":"Glutamate neurotoxicity and diseases of the nervous system","volume":"1","author":"Choi","year":"1988","journal-title":"Neuron"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.284.5412.336","article-title":"NMDA receptor-mediated K+ efflux and neuronal apoptosis","volume":"284","author":"Yu","year":"1999","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12975-013-0314-x","article-title":"Ionic regulation of cell volume changes and cell death after ischemic stroke","volume":"5","author":"Song","year":"2014","journal-title":"Transl. Stroke Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1994.tb44398.x","article-title":"Calcium hypothesis of Alzheimer\u2019s disease and brain aging","volume":"747","author":"Khachaturian","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association Calcium Hypothesis Workgroup (2017). Calcium Hypothesis of Alzheimer\u2019s disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis. Alzheimer\u2019s Dement., 13, 178\u2013182.e17.","DOI":"10.1016\/j.jalz.2016.12.006"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/alz.12398","article-title":"Pathogenesis of sporadic Alzheimer\u2019s disease by deficiency of NMDA receptor subunit GluN3A","volume":"12","author":"Zhong","year":"2022","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2015.3058","article-title":"Acute stroke intervention: A systematic review","volume":"313","author":"Prabhakaran","year":"2015","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s12035-015-9278-z","article-title":"Cerebral Ischemic Preconditioning: The Road So Far","volume":"53","author":"Sangwan","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1527-3458.2003.tb00254.x","article-title":"The neuropharmacological basis for the use of memantine in the treatment of Alzheimer\u2019s disease","volume":"9","author":"Rogawski","year":"2003","journal-title":"CNS Drug Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","article-title":"Duration of preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease in relation to age, sex, and APOE genotype","volume":"15","author":"Vermunt","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","article-title":"On the path to 2025: Understanding the Alzheimer\u2019s disease continuum","volume":"9","author":"Aisen","year":"2017","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40035-021-00260-3","article-title":"NMDAR-dependent somatic potentiation of synaptic inputs is correlated with beta amyloid-mediated neuronal hyperactivity","volume":"10","author":"Bao","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10072-016-2546-5","article-title":"Dysfunction of NMDA receptors in Alzheimer\u2019s disease","volume":"37","author":"Zhang","year":"2016","journal-title":"Neurol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1073\/pnas.1206171109","article-title":"Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease","volume":"109","author":"Busche","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X15666170116143743","article-title":"The Amyloid Cascade Hypothesis in Alzheimer\u2019s Disease: It\u2019s Time to Change Our Mind","volume":"15","author":"Ricciarelli","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nn.4017","article-title":"The case for rejecting the amyloid cascade hypothesis","volume":"18","author":"Herrup","year":"2015","journal-title":"Nat. Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kametani, F., and Hasegawa, M. (2018). Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer\u2019s Disease. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00025"},{"key":"ref_29","first-page":"135","article-title":"Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease","volume":"2","author":"Morris","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-022-00523-1","article-title":"Alzheimer\u2019s disease\u2014The journey of a healthy brain into organ failure","volume":"17","author":"Golde","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3233\/JAD-231377","article-title":"Olfactory Dysfunction and Alzheimer\u2019s Disease: A Review","volume":"99","author":"McLaren","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jns.2012.08.028","article-title":"Evaluation of olfactory dysfunction in neurodegenerative diseases","volume":"323","author":"Barresi","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Shehjar, F., Almarghalani, D.A., Mahajan, R., Hasan, S.A., and Shah, Z.A. (2024). The Multifaceted Role of Cofilin in Neurodegeneration and Stroke: Insights into Pathogenesis and Targeting as a Therapy. Cells, 13.","DOI":"10.3390\/cells13020188"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/alz.12562","article-title":"A new definition of brain reserve","volume":"18","author":"Hachinski","year":"2022","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1002\/alz.13374","article-title":"Strain hypothesis and additional evidence of the GluN3A deficiency-mediated pathogenesis of Alzheimer\u2019s disease","volume":"19","author":"Yu","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4103\/NRR.NRR-D-24-00398","article-title":"Acute and chronic excitotoxicity in ischemic stroke and late-onset Alzheimer\u2019s disease","volume":"20","author":"Yu","year":"2025","journal-title":"Neural Regen. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3233\/JAD-121990","article-title":"Slow excitotoxicity in Alzheimer\u2019s disease","volume":"35","author":"Ong","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","article-title":"Alzheimer\u2019s disease","volume":"167","author":"Gonzalez","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer\u2019s Disease: Epidemiology and Clinical Progression","volume":"11","author":"Byrnes","year":"2022","journal-title":"Neurol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gu, X., Yu, S.P., Jiang, M.Q., Zhong, W., Sastry, A., and Wei, L. (Neurosci. Bull., 2025). Preventive Memantine Treatment at the Preclinical Stage in the Alzheimer\u2019s Disease Model of the 5xFAD Mouse, Neurosci. Bull., online ahead of print.","DOI":"10.1007\/s12264-025-01525-x"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/30748","article-title":"Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A","volume":"393","author":"Das","year":"1998","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-9-13","article-title":"Abundance of Abeta(5)-x like immunoreactivity in transgenic 5XFAD, APP\/PS1KI and 3xTG mice, sporadic and familial Alzheimer\u2019s disease","volume":"9","author":"Guzman","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1113\/jphysiol.2012.239251","article-title":"Regulatory roles of the NMDA receptor GluN3A subunit in locomotion, pain perception and cognitive functions in adult mice","volume":"591","author":"Mohamad","year":"2013","journal-title":"J. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s00429-015-1099-3","article-title":"Expression of the NMDA receptor subunit GluN3A (NR3A) in the olfactory system and its regulatory role on olfaction in the adult mouse","volume":"221","author":"Lee","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/14740330802528420","article-title":"Memantine: A comprehensive review of safety and efficacy","volume":"8","author":"Kavirajan","year":"2009","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14336\/AD.2019.0507","article-title":"Neuropsychological Deficits Chronically Developed after Focal Ischemic Stroke and Beneficial Effects of Pharmacological Hypothermia in the Mouse","volume":"11","author":"Zhong","year":"2020","journal-title":"Aging Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/bpa.12425","article-title":"Long-term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice","volume":"27","author":"Jiang","year":"2017","journal-title":"Brain Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/jcbfm.1990.47","article-title":"A semiautomated method for measuring brain infarct volume","volume":"10","author":"Swanson","year":"1990","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuroscience.2013.01.059","article-title":"Effects of memantine and melatonin on signal transduction pathways vascular leakage and brain injury after focal cerebral ischemia in mice","volume":"237","author":"Kilic","year":"2013","journal-title":"Neuroscience"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Reed, S., Taka, E., Darling-Reed, S., and Soliman, K.F.A. (2025). Neuroprotective Effects of Metformin Through the Modulation of Neuroinflammation and Oxidative Stress. Cells, 14.","DOI":"10.3390\/cells14141064"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"118020","DOI":"10.1016\/j.lfs.2020.118020","article-title":"The role of CREB and BDNF in neurobiology and treatment of Alzheimer\u2019s disease","volume":"257","author":"Amidfar","year":"2020","journal-title":"Life Sci."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Volloch, V., and Rits-Volloch, S. (2024). On the Inadequacy of the Current Transgenic Animal Models of Alzheimer\u2019s Disease: The Path Forward. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052981"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Sasaguri, H., Hashimoto, S., Watamura, N., Sato, K., Takamura, R., Nagata, K., Tsubuki, S., Ohshima, T., Yoshiki, A., and Sato, K. (2022). Recent Advances in the Modeling of Alzheimer\u2019s Disease. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.807473"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/153331750502000206","article-title":"Memantine: Targeting glutamate excitotoxicity in Alzheimer\u2019s disease and other dementias","volume":"20","author":"Molinuevo","year":"2005","journal-title":"Am. J. Alzheimer\u2019s Dis. Other Demen"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer\u2019s disease, beta-amyloid, glutamate, NMDA receptors and memantine--searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s10072-025-08023-y","article-title":"\u201cAdvances in biomarker discovery and diagnostics for alzheimer\u2019s disease\u201d","volume":"46","author":"Bhatia","year":"2025","journal-title":"Neurol. Sci."},{"key":"ref_59","first-page":"27","article-title":"Biomarkers in Alzheimer\u2019s disease","volume":"2","author":"Janeiro","year":"2021","journal-title":"Adv. Lab. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13024-024-00776-y","article-title":"Aging-associated sensory decline and Alzheimer\u2019s disease","volume":"19","author":"Hong","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1570-9639(02)00455-7","article-title":"Coupling of extrasynaptic NMDA receptors to a CREB shut-off pathway is developmentally regulated","volume":"1600","author":"Hardingham","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Kitazawa","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41419-020-2615-9","article-title":"Astrocytic BDNF and TrkB regulate severity and neuronal activity in mouse models of temporal lobe epilepsy","volume":"11","author":"Longueville","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"22687","DOI":"10.1073\/pnas.1012851108","article-title":"CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"107","author":"Caccamo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Ge, L., Liu, S., Rubin, L., Lazarovici, P., and Zheng, W. (2022). Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity. Cells, 11.","DOI":"10.3390\/cells11040666"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"109737","DOI":"10.1016\/j.neuropharm.2023.109737","article-title":"Memantine: Updating a rare success story in pro-cognitive therapeutics","volume":"244","author":"Parsons","year":"2024","journal-title":"Neuropharmacology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jgs.15069","article-title":"Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer\u2019s Disease: Systematic Review and Network Metaanalysis","volume":"66","author":"Tricco","year":"2018","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00002018-200831070-00003","article-title":"Memantine for the treatment of Alzheimer\u2019s disease: Tolerability and safety data from clinical trials","volume":"31","author":"Farlow","year":"2008","journal-title":"Drug Saf."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13041-018-0357-8","article-title":"Targeting NMDA receptors in stroke: New hope in neuroprotection","volume":"11","author":"Wu","year":"2018","journal-title":"Mol. Brain"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1161\/STROKEAHA.114.002879","article-title":"Reprogramming the response to stroke by preconditioning","volume":"45","author":"Stevens","year":"2014","journal-title":"Stroke"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cbpa.2006.08.032","article-title":"Mechanisms of neuroprotection during ischemic preconditioning: Lessons from anoxic tolerance","volume":"147","year":"2007","journal-title":"Comp. Biochem. Physiol. A Mol. Integr. Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Mijajlovic, M.D., Pavlovic, A., Brainin, M., Heiss, W.D., Quinn, T.J., Ihle-Hansen, H.B., Hermann, D.M., Assayag, E.B., Richard, E., and Thiel, A. (2017). Post-stroke dementia\u2014A comprehensive review. BMC Med., 15.","DOI":"10.1186\/s12916-017-0779-7"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1179\/1074935714Z.0000000013","article-title":"What are the correlates of cognition and participation to return to work after first ever mild stroke?","volume":"22","author":"Fride","year":"2015","journal-title":"Top. Stroke Rehabil."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.expneurol.2006.09.006","article-title":"Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse","volume":"203","author":"Bouet","year":"2007","journal-title":"Exp. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1172\/JCI120412","article-title":"Abolition of aberrant neurogenesis ameliorates cognitive impairment after stroke in mice","volume":"129","author":"Cuartero","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"C570","DOI":"10.1152\/ajpcell.00353.2014","article-title":"A neuroprotective role of the NMDA receptor subunit GluN3A (NR3A) in ischemic stroke of the adult mouse","volume":"308","author":"Lee","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10571-020-00924-0","article-title":"Building a Bridge Between NMDAR-Mediated Excitotoxicity and Mitochondrial Dysfunction in Chronic and Acute Diseases","volume":"41","author":"Mira","year":"2021","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pharmthera.2016.02.009","article-title":"A beacon of hope in stroke therapy-Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies","volume":"160","author":"Hoque","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuropharm.2013.04.014","article-title":"NMDA receptors and memory encoding","volume":"74","author":"Morris","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Kniffin, A.R., and Briand, L.A. (2024). Sex differences in glutamate transmission and plasticity in reward related regions. Front. Behav. Neurosci., 18.","DOI":"10.3389\/fnbeh.2024.1455478"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Torrisi, S.A., Rizzo, S., Laudani, S., Ieraci, A., Drago, F., and Leggio, G.M. (2023). Acute stress alters recognition memory and AMPA\/NMDA receptor subunits in a sex-dependent manner. Neurobiol. Stress, 25.","DOI":"10.1016\/j.ynstr.2023.100545"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/23\/1871\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:26:25Z","timestamp":1764307585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/23\/1871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":82,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["cells14231871"],"URL":"https:\/\/doi.org\/10.3390\/cells14231871","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}